Tour de France

Frank Schleck to claim “poisoning” if B sample positive

Frank Schleck (RadioShack-Nissan-Trek) has “categorically denied” doping after failing a drugs test at the end of stage 13 of the 2012 Tour de France.

Frank Schleck has protested his innocence after failing a drugs test at the end of stage 13 of the 2012 Tour de France

The 32-year-old Luxembourger, who finished third in last year’s Tour, and led the team at the Giro d’Italia in May, tested positive for the banned diuretic, Xipamide, at the end of stage 13 from Saint-Paul-Trois-Châteaux to Le Cap d’Agde.

The UCI confirmed the sample had been given on Saturday July 14, during an in competition test, and returned an “Adverse Analytical Finding”.

Reuters reported a statement sent by Frank Schleck to Luxembourg’s RTL broadcast network.

“I categorically deny taking any banned substance. I have no explanation for the test result and therefore insist that the B sample be tested which is my right,” said Frank Schleck.

The B sample test must occur within the next four days.

Frank Schleck continued: “If this analysis confirms the initial result, I will argue that I have been the victim of poisoning.”

A statement on the RadioShack-Nissan-Trek website confirmed that Schleck had left the Tour de France, despite not being required to do so by the UCI.

It pledged the team’s full cooperation with any subsequent investigation.

“On the subject of Xipamide the team can declare the following: it is not a product that is present in any of the medicine that the team uses and the reason for the presence of Xipamide in the urine sample of Mr [Frank] Schleck is unclear to the team. Therefore, the team is not able to explain the adverse findings at this point,” the statement said.


Newsletter Terms & Conditions

Please enter your email so we can keep you updated with news, features and the latest offers. If you are not interested you can unsubscribe at any time. We will never sell your data and you'll only get messages from us and our partners whose products and services we think you'll enjoy.

Read our full Privacy Policy as well as Terms & Conditions.